Cargando…
Baseline peripheral neuropathy was associated with age and a prognostic factor in newly diagnosed multiple myeloma patients
Multiple myeloma (MM) is an incurable plasma cell hematological malignancy. Bortezomib has become the primary drug in the treatment of patients with MM. However, its negative effects, especially peripheral neuropathy (PN), affect the patients’ life quality and treatment continuity. However, there ar...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203796/ https://www.ncbi.nlm.nih.gov/pubmed/35710565 http://dx.doi.org/10.1038/s41598-022-13935-2 |